Status:

COMPLETED

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study

Lead Sponsor:

Leiden University Medical Center

Collaborating Sponsors:

ZonMw: The Netherlands Organisation for Health Research and Development

Health Holland

Conditions:

HCC

Early Stage HCC

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In this multi-center, dose-finding study, patients with early stage hepatocellular carcinoma according to the Barcelona Clinic Liver Cancer (BCLC) staging system will be included to receive percutaneo...

Detailed Description

RFA + adjuvant radioembolsation with Quirem Spheres

Eligibility Criteria

Inclusion

  • Informed consent
  • Age \> 18 years
  • Single HCC lesion with diameter of ≥ 2-5cm or up to three lesions with each lesion measuring no more than 3cm (confined to one lobe)
  • HCC diagnosis is based on histology or non-invasive imaging criteria according to EORTC-EASL guidelines
  • Child Pugh A or B ≤7
  • ECOG performance status ≤ 2
  • Bilirubin \< 2mg/dL
  • ASAT \< 5x upper limit of normal
  • ALAT \< 5x upper limit of normal
  • Thrombocytes ≥ 50 X 10\^9/L

Exclusion

  • Recurrent HCC
  • Tumor location precluding percutaneous RFA
  • Bilobar tumor involvement
  • Vascular tumor invasion or extrahepatic metastasis
  • Hemihepatectomy
  • Severe comorbidity (e.g. cardiovascular disease, diabetes with nephropathy, active infections)
  • Uncorrectable coagulopathy
  • Large arterio-portovenous shunt
  • Previous radiotherapy to the liver
  • Surgical hepatico-enterostomy
  • Hepatic resection with placement of surgical clips that may cause artefacts on MRI
  • Incompetent/ mentally disabled
  • Pregnancy, inadequate anticonception
  • Calculated lung dose \>30Gy
  • Creatinine clearance \< 50 ml/min

Key Trial Info

Start Date :

July 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 17 2021

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03437382

Start Date

July 1 2018

End Date

March 17 2021

Last Update

March 18 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Leiden University Medical Center

Leiden, South Holland, Netherlands, 2333ZA